1. Home
  2. BOX vs TLX Comparison

BOX vs TLX Comparison

Compare BOX & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$26.46

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.66

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
TLX
Founded
2005
2015
Country
United States
Australia
Employees
N/A
1184
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
BOX
TLX
Price
$26.46
$10.66
Analyst Decision
Buy
Strong Buy
Analyst Count
8
4
Target Price
$35.57
$21.13
AVG Volume (30 Days)
2.0M
202.9K
Earning Date
05-26-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$506,142,000.00
N/A
Revenue This Year
$9.41
N/A
Revenue Next Year
$8.15
N/A
P/E Ratio
$311.63
$150.33
Revenue Growth
26.98
N/A
52 Week Low
$21.34
$6.28
52 Week High
$34.39
$16.95

Technical Indicators

Market Signals
Indicator
BOX
TLX
Relative Strength Index (RSI) 55.13 62.06
Support Level $25.74 $9.46
Resistance Level $26.45 $11.28
Average True Range (ATR) 0.81 0.28
MACD -0.08 0.17
Stochastic Oscillator 78.93 77.15

Price Performance

Historical Comparison
BOX
TLX

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: